94 related articles for article (PubMed ID: 10381281)
1. Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes.
Deigner HP; Kinscherf R; Claus R; Fyrnys B; Blencowe C; Hermetter A
Atherosclerosis; 1999 May; 144(1):79-90. PubMed ID: 10381281
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone.
Bittman R; Witzke NM; Lee TC; Blank ML; Snyder F
J Lipid Res; 1987 Jun; 28(6):733-8. PubMed ID: 3611974
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
4. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor.
Suzuki Y; Miwa M; Harada M; Matsumoto M
Eur J Biochem; 1988 Feb; 172(1):117-20. PubMed ID: 3345757
[TBL] [Abstract][Full Text] [Related]
5. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor.
Elstad MR; Stafforini DM; McIntyre TM; Prescott SM; Zimmerman GA
J Biol Chem; 1989 May; 264(15):8467-70. PubMed ID: 2722780
[TBL] [Abstract][Full Text] [Related]
7. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human fetal membranes and decidua vera.
Ban C; Billah MM; Truong CT; Johnston JM
Arch Biochem Biophys; 1986 Apr; 246(1):9-18. PubMed ID: 3963833
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis of paf-acether. XIV. Paf-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase.
Palmantier R; Dulioust A; Maiza H; Benveniste J; Ninio E
Biochem Biophys Res Commun; 1989 Jul; 162(1):475-82. PubMed ID: 2751666
[TBL] [Abstract][Full Text] [Related]
10. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
[TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases.
Yanoshita R; Kudo I; Ikizawa K; Chang HW; Kobayashi S; Ohno M; Nojima S; Inoue K
J Biochem; 1988 May; 103(5):815-9. PubMed ID: 3182751
[TBL] [Abstract][Full Text] [Related]
12. Activity of platelet-activating factor acetylhydrolase exists in red cell membrane.
Yoshida H; Satoh K; Imaizumi T
Am J Hematol; 1992 May; 40(1):61-3. PubMed ID: 1566749
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.
Tjoelker LW; Wilder C; Eberhardt C; Stafforini DM; Dietsch G; Schimpf B; Hooper S; Le Trong H; Cousens LS; Zimmerman GA; Yamada Y; McIntyre TM; Prescott SM; Gray PW
Nature; 1995 Apr; 374(6522):549-53. PubMed ID: 7700381
[TBL] [Abstract][Full Text] [Related]
14. Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein.
Blencowe C; Hermetter A; Kostner GM; Deigner HP
J Biol Chem; 1995 Dec; 270(52):31151-7. PubMed ID: 8537378
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity and partial characterization of the PAF-acylhydrolase in human serum that rapidly inactivates platelet-activating factor.
Wardlow ML; Cox CP; Meng KE; Greene DE; Farr RS
J Immunol; 1986 May; 136(9):3441-6. PubMed ID: 3514760
[TBL] [Abstract][Full Text] [Related]
16. Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis.
Dentan C; Lesnik P; Chapman MJ; Ninio E
Eur J Biochem; 1996 Feb; 236(1):48-55. PubMed ID: 8617285
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of platelet-activating factor acetylhydrolase from peritoneal fluid obtained from guinea pigs after endotoxin shock.
Karasawa K; Yato M; Setaka M; Nojima S
J Biochem; 1994 Aug; 116(2):374-9. PubMed ID: 7822257
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of phospholipids of oxidizing LDL to enzymatic hydrolysis modulates uptake by P388D1 macrophage-like cells.
Fyrnys B; Blencowe C; Deigner HP
FEBS Lett; 1995 Jan; 357(1):7-12. PubMed ID: 8001682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
